Does LURBINECTEDIN Cause Myelosuppression? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Myelosuppression have been filed in association with LURBINECTEDIN (ZEPZELCA). This represents 1.4% of all adverse event reports for LURBINECTEDIN.
13
Reports of Myelosuppression with LURBINECTEDIN
1.4%
of all LURBINECTEDIN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Myelosuppression From LURBINECTEDIN?
Of the 13 reports, 3 (23.1%) required hospitalization.
Is Myelosuppression Listed in the Official Label?
Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for LURBINECTEDIN.
What Other Side Effects Does LURBINECTEDIN Cause?
Death (129)
Disease progression (98)
Off label use (69)
Neutropenia (59)
Nausea (58)
Thrombocytopenia (48)
Fatigue (43)
Febrile neutropenia (39)
Vomiting (37)
Asthenia (36)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which LURBINECTEDIN Alternatives Have Lower Myelosuppression Risk?
LURBINECTEDIN vs LUSPATERCEPT
LURBINECTEDIN vs LUSPATERCEPT-AAMT
LURBINECTEDIN vs LUTEIN
LURBINECTEDIN vs LUTETIUM LU-177
LURBINECTEDIN vs LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN